University of Oulu

Wolford E, Lahti M, Tuovinen S, Lahti J, Lipsanen J, Savolainen K, et al. (2017) Maternal depressive symptoms during and after pregnancy are associated with attention-deficit/hyperactivity disorder symptoms in their 3- to 6-year-old children. PLoS ONE 12(12): e0190248. https://doi.org/10.1371/journal.pone.0190248

Maternal depressive symptoms during and after pregnancy are associated with attention-deficit/hyperactivity disorder symptoms in their 3- to 6-year-old children

Saved in:
Author: Wolford, Elina1; Lahti, Marius1,2; Tuovinen, Soile1;
Organizations: 1Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki
2University/British Heart Foundation Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh
3Helsinki Collegium for Advanced Studies, University of Helsinki
4Folkhälsan Research Centre
5Department of Clinical Chemistry, University of Helsinki
6National Institute for Health and Welfare
7Children’s Hospital, Helsinki University Hospital and University of Helsinki
8PEDEGO Research Unit, MRC Oulu, Oulu University Hospital and University of Oulu
9Obstetrics and Gynaecology, University of Helsinki and Helsinki University Hospital
10Faculty of Medicine and Life Sciences, University of Tampere
11Department of Obstetrics and Gynecology, Tampere University Hospital
12Medical and Clinical Genetics, University of Helsinki and Helsinki University Hospital
13Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki
Format: article
Version: published version
Access: open
Online Access: PDF Full Text (PDF, 1.4 MB)
Persistent link: http://urn.fi/urn:nbn:fi-fe201802083221
Language: English
Published: Public Library of Science, 2017
Publish Date: 2018-02-08
Description:

Abstract

Maternal depressive symptoms during pregnancy have been associated with child behavioural symptoms of attention-deficit/hyperactivity disorder (ADHD) in early childhood. However, it remains unclear if depressive symptoms throughout pregnancy are more harmful to the child than depressive symptoms only during certain times, and if maternal depressive symptoms after pregnancy add to or mediate any prenatal effects. 1,779 mother-child dyads participated in the Prediction and Prevention of Pre-eclampsia and Intrauterine Growth Restriction (PREDO) study. Mothers filled in the Center of Epidemiological Studies Depression Scale biweekly from 12+0–13+6 to 38+0–39+6 weeks+days of gestation or delivery, and the Beck Depression Inventory-II and the Conners’ Hyperactivity Index at the child’s age of 3 to 6 years (mean 3.8 years, standard deviation [SD] 0.5). Maternal depressive symptoms were highly stable throughout pregnancy, and children of mothers with consistently high depressive symptoms showed higher average levels (mean difference = 0.46 SD units, 95% Confidence Interval [CI] 0.36, 0.56, p < 0.001 compared to the low group), and proportion (32.1% vs. 14.7%) and odds (odds ratio = 2.80, 95% CI 2.20, 3.57, p < 0.001) of clinically significant ADHD symptoms. These associations were not explained by the effects of maternal depressive symptoms after pregnancy, which both added to and partially mediated the prenatal effects. Maternal depressive symptoms throughout pregnancy are associated with increased ADHD symptomatology in young children. Maternal depressive symptoms after pregnancy add to, but only partially mediate, the prenatal effects. Preventive interventions suited for the pregnancy period may benefit both maternal and offspring mental health.

see all

Series: PLoS one
ISSN: 1932-6203
ISSN-E: 1932-6203
ISSN-L: 1932-6203
Volume: 12
Issue: 12
Article number: e0190248
DOI: 10.1371/journal.pone.0190248
OADOI: https://oadoi.org/10.1371/journal.pone.0190248
Type of Publication: A1 Journal article – refereed
Field of Science: 3123 Gynaecology and paediatrics
3124 Neurology and psychiatry
Subjects:
Funding: The PREDO study is funded by the Academy of Finland, EraNet, EVO (a special state subsidy for health science research), University of Helsinki Research Funds, the Signe and Ane Gyllenberg Foundation, the Emil Aaltonen Foundation, the Finnish Medical Foundation, the Jane and Aatos Erkko Foundation, the Novo Nordisk Foundation, the Päivikki and Sakari Sohlberg Foundation, the Sigrid Juselius Foundation, and the Sir Jules Thorn Charitable Trust.
Copyright information: © 2017 Wolford et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
  https://creativecommons.org/licenses/by/4.0/